Blog

Dec 3, 2019

Company claims signs of success with CRISPR-edited stem cell transplants for two genetic diseases

Posted by in categories: biotech/medical, genetics

Editing of hemoglobin gene leads two people with different conditions to no longer need regular blood transfusions.

Leave a reply